NYR Nyrada Inc
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Wednesday 18 November 2026
4:30pm · New South Wales · Confirmed
Last AGM voting results
Results of the AGM held Wednesday 12 November 2025.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | Re-election of Mr. John Moore as Director | 100.00% | 0.00% | carried |
| 2 | Re-election of Mr. Christopher Cox as Director | 100.00% | 0.00% | carried |
| 3 | Re-election of Dr. Ian Dixon as Director | 100.00% | 0.00% | carried |
| 4 | Re-election of Mr. Marcus Frampton as Director | 100.00% | 0.00% | carried |
| 5 | Re-election of Dr. Rüdiger Weseloh as Director | 100.00% | 0.00% | carried |
| 6 | Election of Mr. James Bonnar as Director | 100.00% | 0.00% | carried |
| 7 | Ratification of Prior Issue of ASX Listing Rule 7.4 | 99.00% | 1.00% | carried |
| 8 | Ratification of Prior Issue of Listing Rule 7.4 | 99.55% | 0.45% | carried |
| 9 | Ratification of Prior Issue of Options under ASX Listing Rule 7.4 | 98.96% | 1.04% | carried |
| 10 | Approval of Issue of CDIs to Mr. John Moore, Chair and Director of the Company | 92.42% | 7.58% | carried |
| 11 | Approval of Issue of CDIs to Mr. Marcus Frampton, Director of the Company | 92.74% | 7.26% | carried |
| 12 | Approval of Issue of CDIs to Dr. Rüdiger Weseloh, Director of the Company | 99.36% | 0.64% | carried |
| 13 | ASX Listing Rule 7.1A Approval of Future Issue of Securities | 99.72% | 0.28% | carried |
| 14 | Approval of Future Issue of Securities under Equity Incentive Plan | 98.28% | 1.72% | carried |
| 15 | Approval of Issue of Incentive Securities to Mr. John Moore, Chair and Director of the Com | 90.10% | 9.90% | carried |
| 16 | Approval of Issue of Incentive Securities to Mr. Christopher Cox, Director of the Company | 98.28% | 1.72% | carried |
| 17 | Approval of Issue of Incentive Securities to Dr. Ian Dixon, Director of the Company | 68.20% | 31.80% | carried |
| 18 | Approval of Issue of Incentive Securities to Mr. Marcus Frampton, Director of the Company | 98.08% | 1.92% | carried |
| 19 | Approval of Issue of Incentive Securities to Dr. Rüdiger Weseloh, Director of the Company | 98.28% | 1.72% | carried |
| 20 | Approval of Equity Incentive Plan | 98.64% | 1.36% | carried |
Protest vote: 20% or more against, or not carried.